Pediatric Dermatology

Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.

The country's only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.

In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.

Researchers shared details of a noninvasive technique that detects abnormal inflammatory cytokine profiles in the skin of asymptomatic infant patients who subsequently develop AD.

The recommendations were recently published in JAMA Dermatology following an extensive literature review, article grading, and a review of research questions.

Swanson shared updates and a look ahead at what is in store for pediatric dermatology.

Burnett recently spoke with Dermatology Times to discuss the background, methods, and findings of the late-breaking INTEGUMENT-PED data, as well as its potential real-world and clinical implications.

Eichenfield discusses the late-breaking data on roflumilast cream 0.05% in the pediatric patient population and its implications.

April W. Armstrong, MD, MPH, shared treatment insights with attendees at the 36th Annual Pre-AAD Meeting of the Society for Pediatric Dermatology.

Kelly M. Cordoro, MD, shared tips on implementing shared decision making in pediatric dermatology dermatology atat annual conference.

Researchers Eric Sanfilippo, BS; Leslie Castelo-Soccio MD, PhD; and Anna Yasmine Kirkorian, MD, discussed the ethical considerations and methods of removal of unwanted hair in young patients.

Maternal mental health conditions are associated with the majority of atopic diseases, according to a study.

In an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.

A look into the effectiveness of dupilumab on patients aged 6-11 with severe AD shows promising results.

Researchers explored the efficacy of a multistep treatment strategy in a younger patient population.

Researchers in China reviewed topical modalities, minoxidil solutions, tofacitinib, and microneedling for pediatric AA.

Among dermatologists specializing in pediatric alopecia areata, a survey found that class 1 and 2 topical corticosteroids are the preferred first-line therapy.

Factors such as nutritional compromise, low levels of vitamin D, and more, negatively affect bone metabolism in this patient population.

In this week’s Pointers With Portela, the 208SkinDoc gives his recommendations for a pre-teen skin care routine.

Additionally, investigators found that several patients in the review had rosacea induced or exacerbated by the use of topical corticosteroids on the face.

Lisa Swanson, MD, PhD, delves into clinical pearls from her SDPA fall conference sessions on infantile hemangiomas and challenging cases in pediatric dermatology.

Francesca Tenconi, president and CEO of Children’s Skin Disease Foundation and Camp Wonder, presented at Fall Clinical 2023 about the challenges of chronic skin conditions in children.

Factors determining severe levels of stress included uncertainty about treatment progress, diagnosis, and treatment path.

In studying pediatric patients with skin of color in a center specializing in pigment and skin of color, investigators described a paucity of literature of such nature.

The approval provides pediatric patients with a steroid-free topical therapy.